Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001146428 | SCV001307171 | likely benign | Stargardt disease 4 | 2017-09-26 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001146429 | SCV001307172 | uncertain significance | Retinal macular dystrophy type 2 | 2017-09-26 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001146430 | SCV001307173 | uncertain significance | Retinitis pigmentosa | 2017-09-26 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001149203 | SCV001310141 | benign | Cone-rod dystrophy 12 | 2017-09-26 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Labcorp Genetics |
RCV001229010 | SCV001401441 | uncertain significance | not provided | 2024-04-25 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 698 of the PROM1 protein (p.Ser698Arg). This variant is present in population databases (rs199727800, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PROM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 900895). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PROM1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV004813801 | SCV005069496 | uncertain significance | Optic atrophy | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734032 | SCV005360182 | uncertain significance | PROM1-related disorder | 2024-09-06 | no assertion criteria provided | clinical testing | The PROM1 c.2094C>A variant is predicted to result in the amino acid substitution p.Ser698Arg. This variant was reported in a heterozygous state in individual with Leber congenital amaurosis (Eisenberger et al 2013. PubMed ID: 24265693); however, this individual was also apparently homozygous for a frameshift variant in RPGRP1. This variant is reported in 0.15% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |